Crossmark

Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation

Crossref DOI link: https://doi.org/10.1007/s12185-021-03188-6

Published Online: 2021-09-14

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ohwada, Chikako https://orcid.org/0000-0001-9648-940X
Yamazaki, Shingo

Shono, Katsuhiro

Kayamori, Kensuke

Hino, Yutaro

Oshima-Hasegawa, Nagisa

Muto, Tomoya

Tsukamoto, Shokichi

Mitsukawa, Shio

Takeda, Yusuke

Mimura, Naoya

Takeuchi, Masahiro

Iseki, Tohru

Onoda, Masahiro

Yokota, Akira

Suzuki, Takaaki

Ishii, Itsuko

Nakaseko, Chiaki

Sakaida, Emiko
License Information

Text and Data Mining valid from 2021-09-14

Version of Record valid from 2021-09-14
More Information

Article History

Received: 29 January 2021

Revised: 24 June 2021

Accepted: 29 June 2021

First Online: 14 September 2021

Declarations

:

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below